Cardaxe engages industry veteran Fred Sancilio, Ph.D., to launch orphan drug program
Cardax announced it has engaged industry veteran and orphan drug expert, Frederick D. Sancilio, Ph.D., to launch the Company's orphan drug development program. Dr. Sancilio has over 40 years of pharma industry experience, including founding and running a leading CRO in the U.S., Asia, and Europe. June 13, 2018